Protein purification market seen reaching $27.4B by 2033

Persistence Market Research projects the global protein purification and isolation market will rise from $12.5 billion in 2026 to $27.4 billion by 2033. Demand from biologics, proteomics, and personalized medicine is driving growth, with North America holding the largest regional share.

Why it matters: - Protein purification and isolation sits at the center of biologics, vaccine, and diagnostic development. - The market’s growth signals rising spending across drug discovery, biopharma manufacturing, and research labs. - Expanding demand for high-purity proteins is also supporting more use of consumables and automated lab systems.

What happened: - Persistence Market Research projected the global protein purification and isolation market at US$12.5 billion in 2026. - The firm estimated the market will reach US$27.4 billion by 2033. - The forecast implies a 11.9% CAGR from 2026 to 2033. - The release highlighted growth in biotechnology, pharmaceutical research, proteomics, and personalized medicine. - North America was identified as the largest regional market.

The details: - Consumables remain the leading product category because resins, columns, kits, and reagents need recurring replacement in research and manufacturing workflows. - Instruments are gaining adoption as laboratories upgrade automation to improve productivity and reproducibility. - Pharmaceutical and biotechnology companies are the largest end-user segment. - Research institutes are increasing spending on proteomics and molecular biology. - Contract research organizations are expanding services as outsourcing demand rises. - The report listed chromatography, filtration, and magnetic separation as technologies improving purification efficiency and scalability. - The market includes products, instruments, and services. - The report also segmented the market by application and end user. - North America leads because of biotechnology research spending, advanced laboratory infrastructure, and major pharmaceutical manufacturers. - Europe holds a significant share, supported by research collaborations and pharmaceutical manufacturing. - Asia Pacific is expanding quickly on higher healthcare investment, biotech growth, academic research, and improving lab infrastructure.

Between the lines: - Biologics and biosimilars are the clearest growth engine because protein purification is a required step in production. - Monoclonal antibodies, recombinant proteins, vaccines, and enzyme-based therapeutics are reinforcing demand across manufacturing sites. - Proteomics is becoming a larger driver as researchers look for biomarkers, disease insights, and personalized medicine applications. - High equipment costs and technical complexity remain barriers, especially for smaller labs and academic institutions. - The strongest future upside appears tied to automation, artificial intelligence, and next-generation purification systems that lower cost and speed workflows.

What's next: - Personalized medicine and cell and gene therapy research are expected to create new application areas. - Emerging economies may add momentum as governments invest in biotech infrastructure and pharmaceutical manufacturing. - The report expects broader use of advanced purification systems as labs seek higher efficiency and scalability. - Key companies in the market include Thermo Fisher Scientific, Danaher, Merck KGaA, Bio-Rad Laboratories, and Agilent Technologies. - The release offered a free sample report and report customization options.

The bottom line: - Protein purification remains a foundational market for drug development, and the next phase of growth looks tied to biologics, automation, and broader global research spending.